Gene: DCLK3
Official Full Name: doublecortin like kinase 3provided by HGNC
Gene Summary: Predicted to enable protein serine/threonine kinase activity. Predicted to be involved in protein localization to nucleus. Predicted to act upstream of or within negative regulation of protein localization to nucleus and peptidyl-serine phosphorylation. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA00017 | DCLK3 Knockout cell line (293T) | Human | DCLK3 | 1:3~1:6 | negative | Online Inquiry |
| KOA06114 | DCLK3 Knockout cell line (AC16) | Human | DCLK3 | 1:3-1:4 | negative | Online Inquiry |
| KOA21557 | DCLK3 Knockout cell line (BEAS-2B) | Human | DCLK3 | 1:3~1:4 | negative | Online Inquiry |
| KOA37003 | DCLK3 Knockout cell line (U-2932) | Human | DCLK3 | 1:2-1:4 | negative | Online Inquiry |
| KOA52410 | DCLK3 Knockout cell line (TPC-1) | Human | DCLK3 | 1:5-1:8 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.